ABCA1 and coronary artery disorder: A previous study has demonstrated that in FH patients, peripheral blood leukocyte ABCA1 promoter methylation levels and plasma HDL-C levels are negatively correlated and that FH patients with CAD exhibit higher ABCA1 promoter methylation levels than those without [14].